Online Inquiry

Global Services. (Creative Biolabs Authorized)

In Vivo CAR Lentiviral Vector Physical Titer Quantification (qPCR/dPCR/ELISA) Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs offers ready-in-vivo CAR lentivirus titer testing via qPCR, dPCR, and ELISA assays. Our testing helps researchers track viral‑vector presence, retention, and pharmacokinetic traits when developing engineered‑cell treatments. We employ high‑sensitivity molecular tools to measure viral genome concentration and tissue distribution. Trustworthy titer results will aid your biodistribution assays and speed up clinical translation for CAR‑cell systems built upon integrating viral carriers.

Introduction

Lentiviral vectors are widely used in engineered immune cell development due to their ability to integrate stably into the genome. Quantitative evaluation of vector levels in vivo provides important information regarding vector exposure, distribution, and clearance characteristics. Published studies have demonstrated that nucleic acid-based quantification methods, including qPCR and digital PCR, enable sensitive measurement of vector genome copies, while immunoassays provide complementary assessment of viral particle-associated signals. These approaches support comprehensive characterization of viral vector behavior during preclinical development.

Fig.1 Method for measuring lentiviral vector infectious titers. (OA Literature) Fig.1 Procedure for determining lentiviral vector infectious titer.¹

Service

During the development of CAR-based cell therapies using integrative viral vector platforms, understanding the initial in vivo exposure level of lentiviral vectors is essential for evaluating vector behavior, biodistribution, and early pharmacokinetic profiles. Creative Biolabs provides customized CAR lentiviral vector physical titer quantification solutions to help researchers characterize. Our service supports:

Quantitative assessment of vector genome levels in plasma, serum, and other biological matrices.
Early-stage vector exposure evaluation to determine the presence and concentration of circulating vector-related signals.
Pharmacokinetic profiling support through time-course sampling and vector clearance monitoring.
Method selection and assay optimization based on project requirements, including qPCR, digital PCR, and immunoassay-based detection strategies.
Data interpretation support for nonclinical studies, enabling informed decisions during CAR therapy development.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Evaluation of In Vivo CAR Lentiviral Vector Physical Titer Quantification (qPCR / dPCR / ELISA) Service. (Creative Biolabs Original)

We offer integrated in vivo CAR lentiviral vector physical titer quantification solutions via qPCR, dPCR and ELISA platforms, supporting vector genome measurement, viral particle assessment and longitudinal pharmacokinetic analysis across various biological samples.

Our Workflow

To commence the service, clients shall provide CAR lentiviral vector information, relevant biological samples (e.g., plasma, serum), and detailed study design information.

Workflow of In Vivo CAR Lentiviral Vector Physical Titer Quantification (qPCR / dPCR / ELISA) Service. (Creative Biolabs Original)

Upon completion, clients will receive a vector quantification report, a pharmacokinetic data summary, and a customized interpretation report to support CAR vector development.

Core Benefits

Sensitive quantification of vector-related signals in complex biological matrices, including plasma and serum samples, enabling reliable monitoring of early-stage vector distribution and persistence profiles.
Flexible analytical workflows combining nucleic acid-based quantification and particle-associated detection methods to provide complementary insights into vector levels and biological behavior.
Experienced support in assay design, sample analysis planning, and data interpretation to help researchers overcome challenges in low-abundance vector detection and in vivo exposure assessment.

FAQs

Q: What is the purpose of In Vivo CAR Lentiviral Vector Physical Titer Quantification?

A: This service is designed to measure vector-related signals after administration and evaluate early in vivo exposure characteristics. The generated data help researchers understand vector behavior and support CAR therapy development studies.

Q: Which samples can be analyzed using this service?

A: Common sample types include plasma and serum samples. Additional biological matrices may be evaluated depending on study objectives and experimental design.

Q: What are the differences between qPCR, dPCR, and ELISA-based detection?

A: qPCR provides sensitive quantitative detection, dPCR enables highly precise absolute quantification, and ELISA-based approaches provide complementary information related to viral particle-associated components. The appropriate method depends on project requirements.

Partner with Us

Creative Biolabs offers specialized quantification services for the physical titer of in vivo CAR lentiviral vectors using qPCR, dPCR, and ELISA. These services support accurate evaluation of vector exposure, biodistribution profiles, and early pharmacokinetic characteristics of engineered viral vector systems. Our experienced scientists can create customized analytical workflows matching your CAR therapy development schedule and regulatory requirements, producing consistent, high-quality data to speed up research progress. Get in touch with our team for further details and to discuss your project.

Reference

Wu, Xueling et al. "Development and validation of a droplet digital PCR method for quantifying lentiviral vector infectious titer." Heliyon vol. 10, 20 e38512. 1 Oct. 2024. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1016/j.heliyon.2024.e38512

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.